Scalp Care Efficacy Evaluation for Premium Scalp Revitalizing Essence

Last updated: August 20, 2025
Sponsor: Hungkuang University
Overall Status: Completed

Phase

N/A

Condition

Hair Loss

Alopecia

Treatment

Base formula plus Centella asiatica extracellular vesicles, IGF-1 & FGF-7

Base formula only

Placebo control

Clinical Study ID

NCT06985121
25-016-A
  • Ages 16-60
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The study aims to evaluate the efficacy of the Premium Scalp Revitalizing Essence on human scalp skin. A total of 60 healthy adults, aged 18 to 60, will be recruited and randomly assigned into five groups receiving different formulations. Participants will use the product once daily for 56 days, and their scalp conditions will be assessed through skin texture tests at multiple time points. Key parameters such as sebum content, overall hair loss, hair density, scalp condition, and hair length will be measured.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Healthy adults of any gender from the age of 18 to 60 years (inclusive).

  • Absence of chronic diseases, major illnesses, or allergies.

  • Major illnesses include cancer, post-stroke disorders, paralysis, acute myocardialinfarction, coro-nary artery bypass surgery, end-stage renal disease, and majororgan transplant or hematopoietic stem cell transplant

Exclusion

Exclusion Criteria:

  • Currently taking any medication or using any scalp care products

Study Design

Total Participants: 60
Treatment Group(s): 6
Primary Treatment: Base formula plus Centella asiatica extracellular vesicles, IGF-1 & FGF-7
Phase:
Study Start date:
April 08, 2025
Estimated Completion Date:
July 31, 2025

Study Description

This is a prospective, randomized, double-blinded, and placebo-controlled study to investigate the effects of Premium Scalp Revitalizing Essence on changes in the skin texture of human scalp skin.

Sixty healthy adults aged from 18 to 60 will be recruited and randomly assigned into five groups, with 12 individuals in each group. Group 1 uses Placebo (Base formula without caffeine and panthenol); Group 2 uses the Base formula (Control with caffeine and panthenol); Group 3 uses Base + IGF-1 & FGF-7; Group 4 uses Base + Centella asiatica extracellular vesicles; Group 5 uses Base + Centella Asiatica Exosome + IGF-1 & FGF-7. Before using the test product, all 60 participants undergo the first scalp skin texture test. After 14 days of using the test product, a second scalp skin texture test is conducted; after 28 days of use, a third test is performed; after 42 days of use, a fourth test is conducted; and after 56 days of use, a fifth test is carried out. The scalp skin texture tests include measurements of skin (1) sebum content, (2) overall hair loss, (3) hair density, (4) scalp condition, (5) hair length, and other parameters. The Sebumeter® SM815 probe of the MPA580 device and the ScalpX Intelligent Scalp Diagnostic System will be used to measure the parameters of the study.

Connect with a study center

  • Hungkuang University

    Taichung 1668399, 433304
    Taiwan

    Site Not Available

  • Hungkuang University

    Taichung City, 433304
    Taiwan

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.